The life sciences and healthcare sector plays a unique role in society. Unlike most industries, success is measured not only by financial performance but also by its contribution to improving health outcomes, quality of life and longevity.

The sector is undergoing significant transformation, driven by scientific innovation, technological advances, evolving regulation and changing healthcare priorities. In Russia, these changes are further shaped by the government’s long-term strategy to strengthen technological sovereignty, accelerate innovation and enhance the global competitiveness of the pharmaceutical industry. Organisations must therefore innovate faster, adopt new technologies and operate effectively within an increasingly complex regulatory environment.

Success in this sector depends on exceptional leadership. Today’s executives must combine deep industry expertise with the ability to lead transformation, make informed decisions in highly regulated environments and balance commercial objectives with regulatory requirements, scientific innovation and patient needs.

SQN advises pharmaceutical, biotechnology, medical technology and healthcare organisations on the identification, assessment and appointment of senior leaders capable of delivering long-term strategic priorities. Drawing on deep sector expertise and an extensive international network, we help organisations build leadership teams that strengthen organisational capabilities, lead complex transformation and create long-term value for patients, organisations and society.